ADA and tuberculosis: Given the difference in disease duration and immunosuppressive load between ADA users and ETN users and also between TNFi users and non-TNFi controls, we cannot exclude the possibility that the difference of 1-year TB risk was actually attributed to a difference in disease activity between the two groups.